世界の感染症迅速診断検査市場2020年:企業別、地域別、種類・用途別

【英語タイトル】Global Infectious Disease Rapid Diagnostic Testing Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20SP08862)・商品コード:GIR20SP08862
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年9月23日(※2024年版があります。お問い合わせください)
・ページ数:122
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療、製薬、バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、感染症迅速診断検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。感染症迅速診断検査の種類別市場規模(アッセイ、プラットフォーム)、用途別市場規模(呼吸器感染症、胃腸感染症、中枢神経系感染症、院内感染症、性感染症、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Abbott Laboratories、Hologic, Inc.、Luminex Corporation、Roche Ltd、DiaSorin S.p.A、Danaher Corporation、Quidel Corporation、bioMerieux S.A.、BGI Group、Mesa Biotech、Cellex Inc.、Thermo Fisher Scientific Inc.、Becton Dickinson、GenMark Diagnostics、CTK Biotech
・地域別グローバル市場分析 2015年-2020年
・感染症迅速診断検査の北米市場(アメリカ、カナダ、メキシコ)
・感染症迅速診断検査のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・感染症迅速診断検査のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・感染症迅速診断検査の南米市場(ブラジル、アルゼンチン)
・感染症迅速診断検査の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:アッセイ、プラットフォーム
・用途別分析:呼吸器感染症、胃腸感染症、中枢神経系感染症、院内感染症、性感染症、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論
【レポートの概要】

Market Overview
The Infectious Disease Rapid Diagnostic Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Infectious Disease Rapid Diagnostic Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

Market segmentation
Infectious Disease Rapid Diagnostic Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Infectious Disease Rapid Diagnostic Testing market has been segmented into:
Assays
Platforms

By Application, Infectious Disease Rapid Diagnostic Testing has been segmented into:
Respiratory Infection
Gastro-Intestinal Infection
Center Nervous System Infection
Hospital Acquired Infection
Sexually Transmitted Infections
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Infectious Disease Rapid Diagnostic Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Infectious Disease Rapid Diagnostic Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Infectious Disease Rapid Diagnostic Testing market.

The report offers in-depth assessment of the growth and other aspects of the Infectious Disease Rapid Diagnostic Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Infectious Disease Rapid Diagnostic Testing Market Share Analysis
Infectious Disease Rapid Diagnostic Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Infectious Disease Rapid Diagnostic Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Infectious Disease Rapid Diagnostic Testing sales, revenue and market share for each player covered in this report.

The major players covered in Infectious Disease Rapid Diagnostic Testing are:
Abbott Laboratories
Hologic, Inc.
Luminex Corporation
Roche Ltd
DiaSorin S.p.A
Danaher Corporation
Quidel Corporation
bioMerieux S.A.
BGI Group
Mesa Biotech
Cellex Inc.
Thermo Fisher Scientific Inc.
Becton Dickinson
GenMark Diagnostics
CTK Biotech
Among other players domestic and global, Infectious Disease Rapid Diagnostic Testing market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

【レポートの目次】

1 Infectious Disease Rapid Diagnostic Testing Market Overview
1.1 Product Overview and Scope of Infectious Disease Rapid Diagnostic Testing
1.2 Classification of Infectious Disease Rapid Diagnostic Testing by Type
1.2.1 Global Infectious Disease Rapid Diagnostic Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Type in 2019
1.2.3 Assays
1.2.4 Platforms
1.3 Global Infectious Disease Rapid Diagnostic Testing Market by Application
1.3.1 Overview: Global Infectious Disease Rapid Diagnostic Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Respiratory Infection
1.3.3 Gastro-Intestinal Infection
1.3.4 Center Nervous System Infection
1.3.5 Hospital Acquired Infection
1.3.6 Sexually Transmitted Infections
1.3.7 Others
1.4 Global Infectious Disease Rapid Diagnostic Testing Market by Regions
1.4.1 Global Infectious Disease Rapid Diagnostic Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Infectious Disease Rapid Diagnostic Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Infectious Disease Rapid Diagnostic Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Infectious Disease Rapid Diagnostic Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Infectious Disease Rapid Diagnostic Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Infectious Disease Rapid Diagnostic Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Infectious Disease Rapid Diagnostic Testing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Hologic, Inc.
2.2.1 Hologic, Inc. Details
2.2.2 Hologic, Inc. Major Business
2.2.3 Hologic, Inc. SWOT Analysis
2.2.4 Hologic, Inc. Product and Services
2.2.5 Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Luminex Corporation
2.3.1 Luminex Corporation Details
2.3.2 Luminex Corporation Major Business
2.3.3 Luminex Corporation SWOT Analysis
2.3.4 Luminex Corporation Product and Services
2.3.5 Luminex Corporation Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Roche Ltd
2.4.1 Roche Ltd Details
2.4.2 Roche Ltd Major Business
2.4.3 Roche Ltd SWOT Analysis
2.4.4 Roche Ltd Product and Services
2.4.5 Roche Ltd Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 DiaSorin S.p.A
2.5.1 DiaSorin S.p.A Details
2.5.2 DiaSorin S.p.A Major Business
2.5.3 DiaSorin S.p.A SWOT Analysis
2.5.4 DiaSorin S.p.A Product and Services
2.5.5 DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Danaher Corporation
2.6.1 Danaher Corporation Details
2.6.2 Danaher Corporation Major Business
2.6.3 Danaher Corporation Product and Services
2.6.4 Danaher Corporation Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.7 Quidel Corporation
2.7.1 Quidel Corporation Details
2.7.2 Quidel Corporation Major Business
2.7.3 Quidel Corporation Product and Services
2.7.4 Quidel Corporation Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.8 bioMerieux S.A.
2.8.1 bioMerieux S.A. Details
2.8.2 bioMerieux S.A. Major Business
2.8.3 bioMerieux S.A. Product and Services
2.8.4 bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.9 BGI Group
2.9.1 BGI Group Details
2.9.2 BGI Group Major Business
2.9.3 BGI Group Product and Services
2.9.4 BGI Group Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.10 Mesa Biotech
2.10.1 Mesa Biotech Details
2.10.2 Mesa Biotech Major Business
2.10.3 Mesa Biotech Product and Services
2.10.4 Mesa Biotech Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.11 Cellex Inc.
2.11.1 Cellex Inc. Details
2.11.2 Cellex Inc. Major Business
2.11.3 Cellex Inc. Product and Services
2.11.4 Cellex Inc. Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.12 Thermo Fisher Scientific Inc.
2.12.1 Thermo Fisher Scientific Inc. Details
2.12.2 Thermo Fisher Scientific Inc. Major Business
2.12.3 Thermo Fisher Scientific Inc. Product and Services
2.12.4 Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.13 Becton Dickinson
2.13.1 Becton Dickinson Details
2.13.2 Becton Dickinson Major Business
2.13.3 Becton Dickinson Product and Services
2.13.4 Becton Dickinson Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.14 GenMark Diagnostics
2.14.1 GenMark Diagnostics Details
2.14.2 GenMark Diagnostics Major Business
2.14.3 GenMark Diagnostics Product and Services
2.14.4 GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2019)
2.15 CTK Biotech
2.15.1 CTK Biotech Details
2.15.2 CTK Biotech Major Business
2.15.3 CTK Biotech Product and Services
2.15.4 CTK Biotech Infectious Disease Rapid Diagnostic Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Infectious Disease Rapid Diagnostic Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Infectious Disease Rapid Diagnostic Testing Players Market Share
3.2.2 Top 10 Infectious Disease Rapid Diagnostic Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Infectious Disease Rapid Diagnostic Testing Revenue and Market Share by Regions
4.2 North America Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
4.5 South America Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
5 North America Infectious Disease Rapid Diagnostic Testing Revenue by Countries
5.1 North America Infectious Disease Rapid Diagnostic Testing Revenue by Countries (2015-2020)
5.2 USA Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
6 Europe Infectious Disease Rapid Diagnostic Testing Revenue by Countries
6.1 Europe Infectious Disease Rapid Diagnostic Testing Revenue by Countries (2015-2020)
6.2 Germany Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
6.3 UK Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
6.4 France Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Revenue by Countries
7.1 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Revenue by Countries (2015-2020)
7.2 China Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
7.5 India Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
8 South America Infectious Disease Rapid Diagnostic Testing Revenue by Countries
8.1 South America Infectious Disease Rapid Diagnostic Testing Revenue by Countries (2015-2020)
8.2 Brazil Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Infectious Disease Rapid Diagnostic Testing by Countries
9.1 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Infectious Disease Rapid Diagnostic Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Infectious Disease Rapid Diagnostic Testing Market Forecast by Type (2019-2024)
10.3 Assays Revenue Growth Rate (2015-2025)
10.4 Platforms Revenue Growth Rate (2015-2025)
11 Global Infectious Disease Rapid Diagnostic Testing Market Segment by Application
11.1 Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Application (2015-2020)
11.2 Infectious Disease Rapid Diagnostic Testing Market Forecast by Application (2019-2024)
11.3 Respiratory Infection Revenue Growth (2015-2020)
11.4 Gastro-Intestinal Infection Revenue Growth (2015-2020)
11.5 Center Nervous System Infection Revenue Growth (2015-2020)
11.6 Hospital Acquired Infection Revenue Growth (2015-2020)
11.7 Sexually Transmitted Infections Revenue Growth (2015-2020)
11.8 Others Revenue Growth (2015-2020)
12 Global Infectious Disease Rapid Diagnostic Testing Market Size Forecast (2021-2025)
12.1 Global Infectious Disease Rapid Diagnostic Testing Market Size Forecast (2021-2025)
12.2 Global Infectious Disease Rapid Diagnostic Testing Market Forecast by Regions (2021-2025)
12.3 North America Infectious Disease Rapid Diagnostic Testing Revenue Market Forecast (2021-2025)
12.4 Europe Infectious Disease Rapid Diagnostic Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Revenue Market Forecast (2021-2025)
12.6 South America Infectious Disease Rapid Diagnostic Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Infectious Disease Rapid Diagnostic Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Infectious Disease Rapid Diagnostic Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Infectious Disease Rapid Diagnostic Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Infectious Disease Rapid Diagnostic Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Infectious Disease Rapid Diagnostic Testing Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Abbott Laboratories Corporate Information, Location and Competitors
Table 7. Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Major Business
Table 8. Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Total Revenue (USD Million) (2017-2018)
Table 9. Abbott Laboratories SWOT Analysis
Table 10. Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Product and Solutions
Table 11. Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Hologic, Inc. Corporate Information, Location and Competitors
Table 13. Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Major Business
Table 14. Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Total Revenue (USD Million) (2018-2019)
Table 15. Hologic, Inc. SWOT Analysis
Table 16. Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Product and Solutions
Table 17. Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Luminex Corporation Corporate Information, Location and Competitors
Table 19. Luminex Corporation Infectious Disease Rapid Diagnostic Testing Major Business
Table 20. Luminex Corporation Infectious Disease Rapid Diagnostic Testing Total Revenue (USD Million) (2017-2018)
Table 21. Luminex Corporation SWOT Analysis
Table 22. Luminex Corporation Infectious Disease Rapid Diagnostic Testing Product and Solutions
Table 23. Luminex Corporation Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Roche Ltd Corporate Information, Location and Competitors
Table 25. Roche Ltd Infectious Disease Rapid Diagnostic Testing Major Business
Table 26. Roche Ltd Infectious Disease Rapid Diagnostic Testing Total Revenue (USD Million) (2017-2018)
Table 27. Roche Ltd SWOT Analysis
Table 28. Roche Ltd Infectious Disease Rapid Diagnostic Testing Product and Solutions
Table 29. Roche Ltd Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. DiaSorin S.p.A Corporate Information, Location and Competitors
Table 31. DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Major Business
Table 32. DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Total Revenue (USD Million) (2017-2018)
Table 33. DiaSorin S.p.A SWOT Analysis
Table 34. DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Product and Solutions
Table 35. DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Danaher Corporation Corporate Information, Location and Competitors
Table 37. Danaher Corporation Infectious Disease Rapid Diagnostic Testing Major Business
Table 38. Danaher Corporation Infectious Disease Rapid Diagnostic Testing Total Revenue (USD Million) (2017-2018)
Table 39. Danaher Corporation SWOT Analysis
Table 40. Danaher Corporation Infectious Disease Rapid Diagnostic Testing Product and Solutions
Table 41. Danaher Corporation Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Quidel Corporation Corporate Information, Location and Competitors
Table 43. Quidel Corporation Infectious Disease Rapid Diagnostic Testing Major Business
Table 44. Quidel Corporation Infectious Disease Rapid Diagnostic Testing Total Revenue (USD Million) (2017-2018)
Table 45. Quidel Corporation SWOT Analysis
Table 46. Quidel Corporation Infectious Disease Rapid Diagnostic Testing Product and Solutions
Table 47. Quidel Corporation Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. bioMerieux S.A. Corporate Information, Location and Competitors
Table 49. bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Major Business
Table 50. bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Total Revenue (USD Million) (2017-2018)
Table 51. bioMerieux S.A. SWOT Analysis
Table 52. bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Product and Solutions
Table 53. bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. BGI Group Corporate Information, Location and Competitors
Table 55. BGI Group Infectious Disease Rapid Diagnostic Testing Major Business
Table 56. BGI Group Infectious Disease Rapid Diagnostic Testing Total Revenue (USD Million) (2017-2018)
Table 57. BGI Group SWOT Analysis
Table 58. BGI Group Infectious Disease Rapid Diagnostic Testing Product and Solutions
Table 59. BGI Group Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Mesa Biotech Corporate Information, Location and Competitors
Table 61. Mesa Biotech Infectious Disease Rapid Diagnostic Testing Major Business
Table 62. Mesa Biotech Infectious Disease Rapid Diagnostic Testing Total Revenue (USD Million) (2017-2018)
Table 63. Mesa Biotech SWOT Analysis
Table 64. Mesa Biotech Infectious Disease Rapid Diagnostic Testing Product and Solutions
Table 65. Mesa Biotech Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Cellex Inc. Corporate Information, Location and Competitors
Table 67. Cellex Inc. Infectious Disease Rapid Diagnostic Testing Major Business
Table 68. Cellex Inc. Infectious Disease Rapid Diagnostic Testing Total Revenue (USD Million) (2017-2018)
Table 69. Cellex Inc. SWOT Analysis
Table 70. Cellex Inc. Infectious Disease Rapid Diagnostic Testing Product and Solutions
Table 71. Cellex Inc. Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Thermo Fisher Scientific Inc. Corporate Information, Location and Competitors
Table 73. Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Major Business
Table 74. Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Total Revenue (USD Million) (2017-2018)
Table 75. Thermo Fisher Scientific Inc. SWOT Analysis
Table 76. Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Product and Solutions
Table 77. Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Becton Dickinson Corporate Information, Location and Competitors
Table 79. Becton Dickinson Infectious Disease Rapid Diagnostic Testing Major Business
Table 80. Becton Dickinson Infectious Disease Rapid Diagnostic Testing Total Revenue (USD Million) (2017-2018)
Table 81. Becton Dickinson SWOT Analysis
Table 82. Becton Dickinson Infectious Disease Rapid Diagnostic Testing Product and Solutions
Table 83. Becton Dickinson Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. GenMark Diagnostics Corporate Information, Location and Competitors
Table 85. GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Major Business
Table 86. GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Total Revenue (USD Million) (2017-2018)
Table 87. GenMark Diagnostics SWOT Analysis
Table 88. GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Product and Solutions
Table 89. GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. CTK Biotech Corporate Information, Location and Competitors
Table 91. CTK Biotech Infectious Disease Rapid Diagnostic Testing Major Business
Table 92. CTK Biotech Infectious Disease Rapid Diagnostic Testing Total Revenue (USD Million) (2017-2018)
Table 93. CTK Biotech SWOT Analysis
Table 94. CTK Biotech Infectious Disease Rapid Diagnostic Testing Product and Solutions
Table 95. CTK Biotech Infectious Disease Rapid Diagnostic Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Global Infectious Disease Rapid Diagnostic Testing Revenue (Million USD) by Players (2015-2020)
Table 97. Global Infectious Disease Rapid Diagnostic Testing Revenue Share by Players (2015-2020)
Table 98. Global Infectious Disease Rapid Diagnostic Testing Revenue (Million USD) by Regions (2015-2020)
Table 99. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Regions (2015-2020)
Table 100. North America Infectious Disease Rapid Diagnostic Testing Revenue by Countries (2015-2020)
Table 101. North America Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Countries (2015-2020)
Table 102. Europe Infectious Disease Rapid Diagnostic Testing Revenue (Million USD) by Countries (2015-2020)
Table 103. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Revenue (Million USD) by Countries (2015-2020)
Table 104. South America Infectious Disease Rapid Diagnostic Testing Revenue by Countries (2015-2020)
Table 105. South America Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Countries (2015-2020)
Table 106. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Revenue (Million USD) by Countries (2015-2020)
Table 107. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Countries (2015-2020)
Table 108. Global Infectious Disease Rapid Diagnostic Testing Revenue (Million USD) by Type (2015-2020)
Table 109. Global Infectious Disease Rapid Diagnostic Testing Revenue Share by Type (2015-2020)
Table 110. Global Infectious Disease Rapid Diagnostic Testing Revenue Forecast by Type (2021-2025)
Table 111. Global Infectious Disease Rapid Diagnostic Testing Revenue by Application (2015-2020)
Table 112. Global Infectious Disease Rapid Diagnostic Testing Revenue Share by Application (2015-2020)
Table 113. Global Infectious Disease Rapid Diagnostic Testing Revenue Forecast by Application (2021-2025)
Table 114. Global Infectious Disease Rapid Diagnostic Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Infectious Disease Rapid Diagnostic Testing Picture
Figure 2. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Type in 2019
Figure 3. Assays Picture
Figure 4. Platforms Picture
Figure 5. Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Application in 2019
Figure 6. Respiratory Infection Picture
Figure 7. Gastro-Intestinal Infection Picture
Figure 8. Center Nervous System Infection Picture
Figure 9. Hospital Acquired Infection Picture
Figure 10. Sexually Transmitted Infections Picture
Figure 11. Others Picture
Figure 12. Global Infectious Disease Rapid Diagnostic Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America Infectious Disease Rapid Diagnostic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe Infectious Disease Rapid Diagnostic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America Infectious Disease Rapid Diagnostic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Infectious Disease Rapid Diagnostic Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global Infectious Disease Rapid Diagnostic Testing Revenue Share by Players in 2019
Figure 20. Global Top 5 Players Infectious Disease Rapid Diagnostic Testing Revenue Market Share in 2019
Figure 21. Global Top 10 Players Infectious Disease Rapid Diagnostic Testing Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global Infectious Disease Rapid Diagnostic Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Regions (2015-2020)
Figure 25. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Regions in 2018
Figure 26. North America Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 27. Europe Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 29. South America Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 31. North America Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Countries (2015-2020)
Figure 32. North America Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Countries in 2019
Figure 33. USA Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 34. Canada Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 35. Mexico Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 36. Europe Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Countries (2015-2020)
Figure 37. Europe Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Countries in 2019
Figure 38. Germany Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 39. UK Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 40. France Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 41. Russia Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 42. Italy Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Countries in 2019
Figure 45. China Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 46. Japan Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 47. Korea Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 48. India Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 50. South America Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Countries (2015-2020)
Figure 51. South America Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Countries in 2019
Figure 52. Brazil Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 53. Argentina Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 57. UAE Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 58. Egypt Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 59. South Africa Infectious Disease Rapid Diagnostic Testing Revenue and Growth Rate (2015-2020)
Figure 60. Global Infectious Disease Rapid Diagnostic Testing Revenue Share by Type (2015-2020)
Figure 61. Global Infectious Disease Rapid Diagnostic Testing Revenue Share by Type in 2019
Figure 62. Global Infectious Disease Rapid Diagnostic Testing Market Share Forecast by Type (2021-2025)
Figure 63. Global Assays Revenue Growth Rate (2015-2020)
Figure 64. Global Platforms Revenue Growth Rate (2015-2020)
Figure 65. Global Infectious Disease Rapid Diagnostic Testing Revenue Share by Application (2015-2020)
Figure 66. Global Infectious Disease Rapid Diagnostic Testing Revenue Share by Application in 2019
Figure 67. Global Infectious Disease Rapid Diagnostic Testing Market Share Forecast by Application (2021-2025)
Figure 68. Global Respiratory Infection Revenue Growth Rate (2015-2020)
Figure 69. Global Gastro-Intestinal Infection Revenue Growth Rate (2015-2020)
Figure 70. Global Center Nervous System Infection Revenue Growth Rate (2015-2020)
Figure 71. Global Hospital Acquired Infection Revenue Growth Rate (2015-2020)
Figure 72. Global Sexually Transmitted Infections Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global Infectious Disease Rapid Diagnostic Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global Infectious Disease Rapid Diagnostic Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America Infectious Disease Rapid Diagnostic Testing Revenue Market Forecast (2021-2025)
Figure 78. Europe Infectious Disease Rapid Diagnostic Testing Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Revenue Market Forecast (2021-2025)
Figure 80. South America Infectious Disease Rapid Diagnostic Testing Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa Infectious Disease Rapid Diagnostic Testing Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

Abbott Laboratories、Hologic, Inc.、Luminex Corporation、Roche Ltd、DiaSorin S.p.A、Danaher Corporation、Quidel Corporation、bioMerieux S.A.、BGI Group、Mesa Biotech、Cellex Inc.、Thermo Fisher Scientific Inc.、Becton Dickinson、GenMark Diagnostics、CTK Biotech

★調査レポート[世界の感染症迅速診断検査市場2020年:企業別、地域別、種類・用途別] (コード:GIR20SP08862)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の感染症迅速診断検査市場2020年:企業別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆